✦ LIBER ✦

Prophylaxis in haemophilia B patients: unresolved issues and pharmacoeconomic implications

✍ Scribed by E. SANTAGOSTINO

Book ID: 108775528
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 99 KB
Volume: 16
Category: Article
ISSN: 1351-8216
DOI: 10.1111/j.1365-2516.2010.02301.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Focusing on haemophilia B: prophylaxis i

Focusing on haemophilia B: prophylaxis in Spanish patients

✍ J. A. AZNAR; J. F. LUCIA; L. ABAD-FRANCH; R. RUBIO; V. JIMENEZ-YUSTE; R. PEREZ; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Pharmacoeconomic analysis of oprelvekin

Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy

✍ Scott B. Cantor; Linda S. Elting; David V. Hudson Jr.; Edward B Rubenstein 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB

## Abstract ## BACKGROUND Previous research has shown oprelvekin (recombinant human interleukin‐11 [rhIL‐11]) to be effective in reducing the requirements for platelet transfusions after myelosuppressive chemotherapy in patients who have previously experienced thrombocytopenia. The economic conseq

The application of bypassing-agent proph

The application of bypassing-agent prophylaxis in haemophilia A patients with inhibitors: a meeting report

✍ L. A. VALENTINO; M. CARCAO; P. MATHEW; C. A. LEISSINGER; E. BERNTORP; V. BLANCHE 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Identification and long-term observation

Identification and long-term observation of early joint damage by magnetic resonance imaging in clinically asymptomatic joints in patients with haemophilia A or B despite prophylaxis

✍ M. OLIVIERI; K. KURNIK; T. PFLUGER; C. BIDLINGMAIER 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB